Inhibrx, Inc.
NASDAQ:INBX
15.55 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 277.924 | 273.865 | 131.301 | 128.664 | 11.54 | 2.103 | 13.47 | 20.025 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 277.924 | 273.865 | 131.301 | 128.664 | 11.54 | 2.103 | 13.47 | 20.025 |
| Net Receivables
| 0.778 | 0.257 | 0.878 | 0.615 | 0.438 | 0.69 | 0.696 | 0 |
| Inventory
| 0 | -0.257 | -0.878 | -129.279 | 3.207 | 2.311 | 0.999 | 0 |
| Other Current Assets
| 16.656 | 6.628 | 7.811 | 132.172 | 0.376 | 0.553 | 0.276 | 0.383 |
| Total Current Assets
| 295.358 | 280.493 | 139.112 | 132.172 | 15.561 | 5.657 | 15.441 | 20.408 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 9.371 | 7.218 | 9.491 | 11.323 | 10.683 | 2.593 | 1.805 | 0.864 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.164 | 3.164 | 1.847 | 0.245 | 0.245 | 1.734 | 0 | -0 |
| Total Non-Current Assets
| 12.535 | 10.382 | 11.338 | 11.568 | 10.928 | 4.327 | 1.805 | 0.864 |
| Total Assets
| 307.893 | 290.875 | 150.45 | 143.74 | 26.489 | 9.984 | 17.246 | 21.272 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 10.954 | 8.326 | 9.125 | 13.458 | 3.115 | 6.53 | 0.775 | 0.167 |
| Short Term Debt
| 2.063 | 1.86 | 1.674 | 1.503 | 4.668 | 5.931 | 5.166 | 4.257 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.166 | 2.034 | 3.081 | 7.939 | 1.631 | 2.607 | 0 |
| Other Current Liabilities
| 43.295 | 17.224 | 9.621 | 13.357 | 4.848 | 2.09 | 0.372 | 0.856 |
| Total Current Liabilities
| 56.312 | 27.576 | 22.454 | 31.399 | 20.57 | 16.182 | 8.92 | 5.28 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 206.968 | 202.069 | 70.47 | 35.951 | 37.065 | 3.563 | 9.494 | 14.661 |
| Deferred Revenue Non-Current
| 0 | 0 | 0.11 | 0.737 | 1 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -0.11 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.11 | 3.173 | 5.143 | 0.18 | 61.423 | 47.882 | 21.252 | 0.092 |
| Total Non-Current Liabilities
| 208.078 | 205.242 | 75.613 | 36.868 | 99.488 | 51.445 | 30.746 | 14.753 |
| Total Liabilities
| 264.39 | 232.818 | 98.067 | 68.267 | 120.058 | 67.627 | 39.666 | 20.033 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 150.45 | 143.74 | 59.507 | 47.519 | 0 | 0 |
| Common Stock
| 0.005 | 0.004 | 0.004 | 0.004 | 0.002 | 0.003 | 0 | 0 |
| Retained Earnings
| -613.734 | -372.373 | -227.147 | -145.379 | -69.255 | -17.855 | -28.771 | -9.247 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -150.45 | -143.74 | -59.507 | -1.705 | -1.029 | 0 |
| Other Total Stockholders Equity
| 657.232 | 430.426 | 279.526 | 220.848 | -24.316 | -85.605 | 1.029 | 0 |
| Total Shareholders Equity
| 43.503 | 58.057 | 52.383 | 75.473 | -93.569 | -57.643 | -28.771 | -9.247 |
| Total Equity
| 43.503 | 58.057 | 52.383 | 75.473 | -93.569 | -57.643 | -22.42 | 1.239 |
| Total Liabilities & Shareholders Equity
| 307.893 | 290.875 | 150.45 | 143.74 | 26.489 | 9.984 | 17.246 | 21.272 |